about
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationPrognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conferenceThe immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomasIdentification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Pathology in prostate research: optimizing the pathological data.DNA methylation gene-based models indicating independent poor outcome in prostate cancer.Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservativelyStandardization of Gleason grading among 337 European pathologists.Staging of prostate cancer.Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancerThe safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancerPrognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.Clear cell carcinoma of the ovary arising in a mucinous cystadenoma.Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohortDNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes.Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancerAssociation between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.Long-term outcome among men with conservatively treated localised prostate cancer.Giardiasis of the stomach.Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRbHeterogeneity and clinical significance of ETV1 translocations in human prostate cancerValidation of a contemporary prostate cancer grading system using prostate cancer death as outcome.Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over.Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate GroupTen testicular trapdoors.Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyAngiolymphoid hyperplasia with eosinophilia in the colon: a novel cause of rectal bleeding.
P50
Q24297526-996F997F-1B87-4C10-AC67-90C429DC197FQ27852034-876BC1C9-B24B-4727-B1A4-7D069DCB2452Q28240127-5C5C98DB-343A-4AB7-9B9C-75ED4D7E0058Q33228606-1987A162-90F4-4DB7-A396-F09436DABF61Q33418902-52B49B43-1E80-4BB5-924C-7F0F4108CEC5Q33846990-1B821DF9-0E0B-49B9-A7D5-47466B32F05EQ33894922-FDEB0193-1A1F-4891-A8F8-93EE556B1B53Q33909029-46209E4B-87B6-4923-B6B2-C0F427097712Q34174356-F4B1259E-3BCD-44DE-8D70-7808BD6AF276Q34247934-65B39E19-316D-41BE-A1D5-C06486846082Q34332454-8CD2E6F3-B355-4F3F-95E5-94316ED18C7FQ34512822-9F3C7F81-875E-4116-B527-51B1B460099FQ34634756-F1B578DF-3894-489C-AD94-7D99D8DCD2B0Q34704983-A09B406A-74E0-4DFC-8402-823EF0158E55Q34854084-34BA0904-AA8E-4CE3-B367-2ACFF51FBF59Q34962331-E8F361C4-4856-4381-9622-E4BB9FB7ABCDQ34972318-34ECAF72-EAB4-42C3-9A5A-BBC2C43F2EC4Q35129471-12DADE10-3103-4D53-BBC1-BA9441687833Q35395344-A806D27E-4ECD-4687-A90C-73C993EA2851Q35540063-49EEA984-49EB-48DE-9053-0823A2ECA0D4Q35784738-4D9E3A4F-FBBB-49DC-8960-0A5B9ECD2E07Q35790439-4C53EB55-7B62-4504-A51B-1A3F32EF0EF6Q35909631-7684ED69-63EA-4ADB-BDA5-C94431DE72D2Q35931316-A0E93A31-3015-4992-9C61-3D7294638261Q36078909-25D6307C-03E3-49F7-ACCB-700550A717C3Q36235936-A104C57A-0923-469B-9AEE-2C826FE08792Q36542804-804C35D2-93DB-4E14-8AEC-58D843A26E10Q36557814-9BCD16A8-29D5-4BB4-B831-861A22351C98Q36609819-C1894D79-19F6-4B78-87F5-BF2556868323Q36610888-08C5B4B1-BE12-49B7-BFD7-40146D915492Q36611890-A454ECCC-2885-437D-AA14-F7DE018F5A19Q36679433-30F5EDEE-4D75-4941-AD1F-BA2B232229EFQ36695399-7A62E8C3-68CC-4091-B5DD-4EBB8ED7D0EDQ36785930-FCB3FE3A-ACC5-4D0B-9A6B-B6A61DBB6FD9Q36898434-F68C4FE7-59ED-4BB0-A861-B39E70852624Q36988134-8C90DD07-B059-469C-BD09-162114DE67FFQ37107552-373CEC9C-BBE8-4E9B-AB20-E03DD9C8EB24Q37108781-294A0BD9-F92E-4429-8A11-FF692F074EEAQ37141933-ADCBE172-CC33-4995-AB17-33F2A08F8858Q37210330-A1D6A024-CEB8-4B7D-9FC2-EE062F60B12D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel Berney
@ast
Daniel Berney
@en
Daniel Berney
@es
Daniel Berney
@nl
Daniel Berney
@sl
type
label
Daniel Berney
@ast
Daniel Berney
@en
Daniel Berney
@es
Daniel Berney
@nl
Daniel Berney
@sl
altLabel
Berney D
@en
prefLabel
Daniel Berney
@ast
Daniel Berney
@en
Daniel Berney
@es
Daniel Berney
@nl
Daniel Berney
@sl
P106
P21
P31
P496
0000-0001-5474-8696